Rocket Pharmaceuticals, Inc. (RCKT)
2.64
-0.06
(-2.22%)
USD |
NASDAQ |
Jun 09, 16:00
2.61
-0.03
(-1.14%)
After-Hours: 20:00
Rocket Pharmaceuticals SG&A Expense (Quarterly) : 17.06M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Replimune Group, Inc. | 18.73M |
| ProKidney Corp. | 11.32M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |
| Sangamo Therapeutics, Inc. | 6.818M |